{"entity":{"type":"insider","cik":"0001530968","url":"/insider/0001530968","json_url":"/insider/0001530968.json","name":"Zaderej Karen L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":20,"first":"2012-11-23","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Zaderej Karen L.","source":"filing","n_filings":20,"first_seen":"2012-11-23","last_seen":"2026-08-18"}],"transactions":[{"id":9291215,"accession":"0001530968-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001530968-26-000004","line_url":"/filing/0001530968-26-000004#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10600.0,"shares_display":"10,600","price_per_share":4.93,"price_display":"4.93","price_state":"stated","total_value":52258.0,"total_display":"52,258.00","total_whole":"52,258","shares_owned_after":49100.0,"shares_owned_after_display":"49,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-18","scope":"insider"},{"id":4651008,"accession":"0001562180-25-003997","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-003997","line_url":"/filing/0001562180-25-003997#line-2","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.99,"price_display":"5.99","price_state":"stated","total_value":29950.0,"total_display":"29,950.00","total_whole":"29,950","shares_owned_after":36500.0,"shares_owned_after_display":"36,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-19","scope":"insider"},{"id":4651001,"accession":"0001562180-25-003997","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-003997","line_url":"/filing/0001562180-25-003997#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.81,"price_display":"5.81","price_state":"stated","total_value":29050.0,"total_display":"29,050.00","total_whole":"29,050","shares_owned_after":31500.0,"shares_owned_after_display":"31,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-19","scope":"insider"},{"id":4045945,"accession":"0001562180-25-003873","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-003873","line_url":"/filing/0001562180-25-003873#line-2","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.47,"price_display":"5.47","price_state":"stated","total_value":27350.0,"total_display":"27,350.00","total_whole":"27,350","shares_owned_after":26500.0,"shares_owned_after_display":"26,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-15","scope":"insider"},{"id":4045943,"accession":"0001562180-25-003873","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-003873","line_url":"/filing/0001562180-25-003873#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.42,"price_display":"5.42","price_state":"stated","total_value":27100.0,"total_display":"27,100.00","total_whole":"27,100","shares_owned_after":21500.0,"shares_owned_after_display":"21,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-14","filed_date":"2025-05-15","scope":"insider"},{"id":3185458,"accession":"0001562180-24-006431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-006431","line_url":"/filing/0001562180-24-006431#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":7.98,"price_display":"7.98","price_state":"stated","total_value":99750.0,"total_display":"99,750.00","total_whole":"99,750","shares_owned_after":16500.0,"shares_owned_after_display":"16,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-21","scope":"insider"},{"id":2298754,"accession":"0000805928-24-000051","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000805928-24-000051","line_url":"/filing/0000805928-24-000051","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39280.0,"shares_display":"39,280","price_per_share":7.68,"price_display":"7.68","price_state":"stated","total_value":301670.4,"total_display":"301,670.40","total_whole":"301,670","shares_owned_after":1124565.0,"shares_owned_after_display":"1,124,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-21","filed_date":"2024-03-25","scope":"insider","n_lines":3},{"id":5426515,"accession":"0000805928-21-000163","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000805928-21-000163","line_url":"/filing/0000805928-21-000163","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41000.0,"shares_display":"41,000","price_per_share":18.468149268292684,"price_display":"18.47","price_state":"stated","total_value":757194.12,"total_display":"757,194.12","total_whole":"757,194","shares_owned_after":816101.0,"shares_owned_after_display":"816,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-06","filed_date":"2021-08-10","scope":"insider","n_lines":4},{"id":5256125,"accession":"0001179110-21-000537","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-000537","line_url":"/filing/0001179110-21-000537#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":1300000.0,"total_display":"1,300,000.00","total_whole":"1,300,000","shares_owned_after":609099.0,"shares_owned_after_display":"609,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-12","scope":"insider"},{"id":3252719,"accession":"0001179110-20-012286","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-012286","line_url":"/filing/0001179110-20-012286#line-2","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":17.81,"price_display":"17.81","price_state":"stated","total_value":62335.0,"total_display":"62,335.00","total_whole":"62,335","shares_owned_after":674099.0,"shares_owned_after_display":"674,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-29","filed_date":"2020-12-30","scope":"insider"},{"id":2089012,"accession":"0001179110-20-012189","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-012189","line_url":"/filing/0001179110-20-012189#line-2","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1275.0,"shares_display":"1,275","price_per_share":16.42,"price_display":"16.42","price_state":"stated","total_value":20935.5,"total_display":"20,935.50","total_whole":"20,936","shares_owned_after":646719.0,"shares_owned_after_display":"646,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-22","scope":"insider"},{"id":3252549,"accession":"0001179110-20-010948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-010948","line_url":"/filing/0001179110-20-010948#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":14.53,"price_display":"14.53","price_state":"stated","total_value":203420.0,"total_display":"203,420.00","total_whole":"203,420","shares_owned_after":644869.0,"shares_owned_after_display":"644,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider"},{"id":8289042,"accession":"0001179110-19-009360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-009360","line_url":"/filing/0001179110-19-009360#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"Axogen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":13.499,"price_display":"13.50","price_state":"stated","total_value":1012425.0,"total_display":"1,012,425.00","total_whole":"1,012,425","shares_owned_after":593280.0,"shares_owned_after_display":"593,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-12","scope":"insider"},{"id":6096118,"accession":"0001179110-18-012898","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-012898","line_url":"/filing/0001179110-18-012898#line-2","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":32.93,"price_display":"32.93","price_state":"stated","total_value":395160.0,"total_display":"395,160.00","total_whole":"395,160","shares_owned_after":382970.0,"shares_owned_after_display":"382,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-14","filed_date":"2018-11-15","scope":"insider"},{"id":6096117,"accession":"0001179110-18-012898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-012898","line_url":"/filing/0001179110-18-012898#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":33.42,"price_display":"33.42","price_state":"stated","total_value":434460.0,"total_display":"434,460.00","total_whole":"434,460","shares_owned_after":394970.0,"shares_owned_after_display":"394,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-13","filed_date":"2018-11-15","scope":"insider"},{"id":2913890,"accession":"0001179110-16-030705","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-030705","line_url":"/filing/0001179110-16-030705#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":242147.0,"shares_owned_after_display":"242,147","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-07","filed_date":"2016-10-14","scope":"insider"},{"id":8645396,"accession":"0001209191-15-047889","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-047889","line_url":"/filing/0001209191-15-047889","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3325.0,"shares_display":"3,325","price_per_share":3.1558646616541353,"price_display":"3.16","price_state":"stated","total_value":10493.25,"total_display":"10,493.25","total_whole":"10,493","shares_owned_after":231447.0,"shares_owned_after_display":"231,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-27","filed_date":"2015-05-29","scope":"insider","n_lines":3},{"id":6295206,"accession":"0001209191-14-038971","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-038971","line_url":"/filing/0001209191-14-038971#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.43,"price_display":"2.43","price_state":"stated","total_value":12150.0,"total_display":"12,150.00","total_whole":"12,150","shares_owned_after":334056.0,"shares_owned_after_display":"334,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-03","filed_date":"2014-06-04","scope":"insider"},{"id":6265957,"accession":"0001209191-14-033187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-033187","line_url":"/filing/0001209191-14-033187#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":13500.0,"total_display":"13,500.00","total_whole":"13,500","shares_owned_after":329056.0,"shares_owned_after_display":"329,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-12","filed_date":"2014-05-13","scope":"insider"},{"id":6676936,"accession":"0001209191-14-021125","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-021125","line_url":"/filing/0001209191-14-021125","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":3.48856,"price_display":"3.49","price_state":"stated","total_value":5232.84,"total_display":"5,232.84","total_whole":"5,233","shares_owned_after":136302.0,"shares_owned_after_display":"136,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-13","filed_date":"2014-03-17","scope":"insider","n_lines":2},{"id":4566509,"accession":"0001209191-13-040863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-040863","line_url":"/filing/0001209191-13-040863#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8334.0,"shares_display":"8,334","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":25002.0,"total_display":"25,002.00","total_whole":"25,002","shares_owned_after":129124.0,"shares_owned_after_display":"129,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-14","filed_date":"2013-08-15","scope":"insider"},{"id":2758568,"accession":"0001209191-12-057343","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-057343","line_url":"/filing/0001209191-12-057343#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":2250.0,"total_display":"2,250.00","total_whole":"2,250","shares_owned_after":120790.0,"shares_owned_after_display":"120,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-10","filed_date":"2012-12-13","scope":"insider"},{"id":2125890,"accession":"0001209191-12-054395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-054395","line_url":"/filing/0001209191-12-054395#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001530968","owner_name":"Zaderej Karen L.","owner_display_name":"Zaderej Karen L.","owner_url":"/insider/0001530968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":269.0,"total_display":"269.00","total_whole":"269","shares_owned_after":119890.0,"shares_owned_after_display":"119,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-20","filed_date":"2012-11-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":18,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001314102","name":"EyePoint, Inc.","url":"/issuer/0001314102","role":"Director","n_filings":4,"first_seen":"2024-08-21","last_seen":"2026-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0000805928","name":"Axogen, Inc.","url":"/issuer/0000805928","role":"Director, Officer (CEO)","n_filings":16,"first_seen":"2012-11-23","last_seen":"2024-03-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001530968","retrieved_at":"2026-08-27T07:11:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}